<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>About | Khalid Almansoori</title>
    <link rel="stylesheet" href="style.css">
</head>

<body>

<header>
    <h2>About Me</h2>
    <h3>Neuropsychopharmacology Researcher</h3>
</header>

<nav style="text-align: center; margin-top: 10px;">
    <a href="index.html">Home</a>
    <a href="links.html">Links</a>
    <a href="about-ar.html">العربية</a>
</nav>

<section>

  <h2>Biography</h2>

<img src="unnamedme1.jpg" alt="Khalid Almansoori" style="width:180px; border-radius:10px; display:block; margin:auto; box-shadow:0 0 12px #00ff88;">



    <strong>Khalid Almansoori</strong> (born in the United Arab Emirates, age: <strong>your age</strong>) is an Emirati neuropsychopharmacology researcher. He is recognized as the <strong>first Emirati neuropsychopharmacologist</strong>, contributing to the emerging field of developmental and behavioral psychopharmacology in the UAE.
  </p>

 <!-- Highlight Box -->
<div style="
    display: flex;
    flex-direction: column;
    align-items: center;
    justify-content: center;
    margin: 25px auto;
    width: 85%;
    background-color: #111;
    border-radius: 12px;
    box-shadow: 0 0 15px #00ff88;
    padding: 15px;
    text-align: center;
    border: 4px solid transparent;
    background-image: 
        linear-gradient(to right, #ff0000, #009739, #ffffff, #000000),
        linear-gradient(#111, #111);
    background-origin: border-box;
    background-clip: padding-box, border-box;
">
    <h2 style="color: black !important; margin-bottom: 10px;">
        First Emirati Neuropsychopharmacologist
    </h2>
    <p style="color: black !important; font-size: 16px;">
        Khalid Almansoori is recognized as the first Emirati to specialize in 
        neuropsychopharmacology, contributing to the development of this emerging 
        scientific field within the United Arab Emirates.
    </p>
</div>


    <h2 style="color: #00ff88; margin-bottom: 10px;">
        First Emirati Neuropsychopharmacologist
    </h2>
    <p style="color: #c8ffc8; font-size: 16px;">
        Khalid Almansoori is recognized as the first Emirati to specialize in 
        neuropsychopharmacology, contributing to the development of this emerging 
        scientific field within the United Arab Emirates.
    </p>
</div>


    border: 3px solid #ff0000; 
    border-left: 3px solid #009739; 
    border-right: 3px solid #ffffff; 
    border-bottom: 3px solid #000000;
    padding: 15px;
    margin: 25px auto;
    width: 85%;
    background-color: rgba(0, 0, 0, 0.6);
    border-radius: 12px;
    box-shadow: 0 0 15px #00ff88;
    text-align: center;
">
    <h2 style="color: #00ff88; margin-bottom: 10px;">
        First Emirati Neuropsychopharmacologist
    </h2>
    <p style="color: #c8ffc8; font-size: 16px;">
        Khalid Almansoori is recognized as the first Emirati to specialize in 
        neuropsychopharmacology, contributing to the development of this emerging 
        scientific field within the United Arab Emirates.
    </p>
</div>

    <p style="margin-top:20px;">
        <strong>Khalid Almansoori</strong> (born in the United Arab Emirates, age: <strong>[your age]</strong>) 
        is an Emirati neuropsychopharmacology researcher. He is recognized as the 
        <strong>first Emirati neuropsychopharmacologist</strong>, contributing to the emerging field of 
        developmental and behavioral psychopharmacology in the UAE.
    </p>

    <p>
        Khalid’s academic work focuses on neurotransmitter systems, including dopamine, serotonin, 
        NMDA receptor pathways, and their roles in cognition, mood regulation, and neurodevelopment. 
        He is currently pursuing advanced studies in neuropsychopharmacology, with research interests 
        spanning psychotropic mechanisms, neurodevelopmental disorders, and translational neuroscience.
    </p>

    <h2>Early Life & Background</h2>
<p>
    Khalid was born and raised in the United Arab Emirates. At the age of 
    <strong>14</strong>, he developed a deep interest in neuroscience and 
    neuropsychopharmacology, driven by a fascination with how neurotransmitters, 
    behavior, and mental health are interconnected. This early curiosity shaped 
    his academic direction and ultimately led him toward specializing in the 
    emerging field of neuropsychopharmacology.
</p>
<h2>Areas of Study</h2>
<ul>
  <li>In vivo research methodologies</li>
  <li>Clinical research and psychopharmacological assessment</li>
  <li>Neurotransmitter system analysis (dopamine, serotonin, GABA, glutamate)</li>
  <li>Behavioral and developmental neuroscience</li>
</ul>
<h2>Future Research Interests</h2>
<p>
    Khalid aims to expand his work into advanced clinical research, with a 
    particular focus on studies planned to be conducted in Japan. His future 
    research goals include exploring psychotropic mechanisms, neurodevelopmental 
    disorders, and translational applications of neuropsychopharmacology within 
    clinical settings. He is especially interested in bridging in vivo research 
    with clinical practice to contribute to global advancements in mental health 
    and neuropharmacological treatment.
</p>


    <h2>Research Interests</h2>
    <ul>
        <li>Neurotransmitter systems (dopamine, serotonin, GABA, glutamate)</li>
        <li>Psychotropic drug mechanisms</li>
        <li>Neurodevelopmental psychopharmacology</li>
        <li>Behavioral neuroscience</li>
        <li>Translational mental health research</li>
    </ul>

    <h2>Professional Identity</h2>
    <p>
        Khalid is committed to advancing neuroscience research in the UAE and aims to contribute 
        to scientific understanding, mental health awareness, and the development of future 
        neuropharmacological innovations.
    </p>

</section>

<a class="floating-whatsapp" href="https://wa.me/971553714800" target="_blank">WhatsApp</a>

</body>
</html>
